147 related articles for article (PubMed ID: 28583201)
21. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
[TBL] [Abstract][Full Text] [Related]
22. Classical ROS-dependent and early/rapid ROS-independent release of Neutrophil Extracellular Traps triggered by Leishmania parasites.
Rochael NC; Guimarães-Costa AB; Nascimento MT; DeSouza-Vieira TS; Oliveira MP; Garcia e Souza LF; Oliveira MF; Saraiva EM
Sci Rep; 2015 Dec; 5():18302. PubMed ID: 26673780
[TBL] [Abstract][Full Text] [Related]
23. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.
Hailu A; van der Poll T; Berhe N; Kager PA
Am J Trop Med Hyg; 2004 Nov; 71(5):561-7. PubMed ID: 15569785
[TBL] [Abstract][Full Text] [Related]
24. Leishmania donovani promastigotes evade the antimicrobial activity of neutrophil extracellular traps.
Gabriel C; McMaster WR; Girard D; Descoteaux A
J Immunol; 2010 Oct; 185(7):4319-27. PubMed ID: 20826753
[TBL] [Abstract][Full Text] [Related]
25. Generation of growth arrested Leishmania amastigotes: a tool to develop live attenuated vaccine candidates against visceral leishmaniasis.
Selvapandiyan A; Dey R; Gannavaram S; Solanki S; Salotra P; Nakhasi HL
Vaccine; 2014 Jun; 32(31):3895-901. PubMed ID: 24837513
[TBL] [Abstract][Full Text] [Related]
26. Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps.
Guimarães-Costa AB; Nascimento MT; Froment GS; Soares RP; Morgado FN; Conceição-Silva F; Saraiva EM
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6748-53. PubMed ID: 19346483
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneity of Leishmania donovani parasites complicates diagnosis of visceral leishmaniasis: comparison of different serological tests in three endemic regions.
Abass E; Kang C; Martinkovic F; Semião-Santos SJ; Sundar S; Walden P; Piarroux R; El Harith A; Lohoff M; Steinhoff U
PLoS One; 2015; 10(3):e0116408. PubMed ID: 25734336
[TBL] [Abstract][Full Text] [Related]
28. Imaging visceral leishmaniasis in real time with golden hamster model: Monitoring the parasite burden and hamster transcripts to further characterize the immunological responses of the host.
Rouault E; Lecoeur H; Meriem AB; Minoprio P; Goyard S; Lang T
Parasitol Int; 2017 Feb; 66(1):933-939. PubMed ID: 27794505
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptor 9 signaling in dendritic cells regulates neutrophil recruitment to inflammatory foci following Leishmania infantum infection.
Sacramento L; Trevelin SC; Nascimento MS; Lima-Jùnior DS; Costa DL; Almeida RP; Cunha FQ; Silva JS; Carregaro V
Infect Immun; 2015 Dec; 83(12):4604-16. PubMed ID: 26371124
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Leishmania donovani disulfide isomerase as a potential target of cellular immunity against visceral leishmaniasis.
Amit A; Chaudhary R; Yadav A; Suman SS; Narayan S; Das VN; Pandey K; Singh SK; Singh BK; Ali V; Das P; Bimal S
Cell Immunol; 2014; 289(1-2):76-85. PubMed ID: 24732062
[TBL] [Abstract][Full Text] [Related]
31. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
Choudhury R; Das P; De T; Chakraborti T
Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
[TBL] [Abstract][Full Text] [Related]
32. A Subset of Neutrophils Expressing Markers of Antigen-Presenting Cells in Human Visceral Leishmaniasis.
Sharma S; Davis RE; Srivastva S; Nylén S; Sundar S; Wilson ME
J Infect Dis; 2016 Nov; 214(10):1531-1538. PubMed ID: 27601622
[TBL] [Abstract][Full Text] [Related]
33. The Severity of Visceral Leishmaniasis Correlates with Elevated Levels of Serum IL-6, IL-27 and sCD14.
Dos Santos PL; de Oliveira FA; Santos ML; Cunha LC; Lino MT; de Oliveira MF; Bomfim MO; Silva AM; de Moura TR; de Jesus AR; Duthie MS; Reed SG; de Almeida RP
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004375. PubMed ID: 26814478
[TBL] [Abstract][Full Text] [Related]
34. Cloning, expression and purification of 3'-nucleotidase/nuclease, an enzyme responsible for the Leishmania escape from neutrophil extracellular traps.
Freitas-Mesquita AL; Dick CF; Dos-Santos ALA; Nascimento MTC; Rochael NC; Saraiva EM; Meyer-Fernandes JR
Mol Biochem Parasitol; 2019 Apr; 229():6-14. PubMed ID: 30772424
[TBL] [Abstract][Full Text] [Related]
35. Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis.
Aguilar-Be I; da Silva Zardo R; Paraguai de Souza E; Borja-Cabrera GP; Rosado-Vallado M; Mut-Martin M; García-Miss Mdel R; Palatnik de Sousa CB; Dumonteil E
Infect Immun; 2005 Feb; 73(2):812-9. PubMed ID: 15664920
[TBL] [Abstract][Full Text] [Related]
36. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
Melby PC; Yang J; Zhao W; Perez LE; Cheng J
Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous leishmaniasis serodiagnosis by immunoperoxidase assay.
Halevy D; Sarov B; Sarov I; el-On J
Isr J Med Sci; 1990 Sep; 26(9):485-90. PubMed ID: 2228558
[TBL] [Abstract][Full Text] [Related]
38. Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis.
Khare P; Jaiswal AK; Tripathi CD; Sundar S; Dube A
Clin Exp Immunol; 2016 Aug; 185(2):165-79. PubMed ID: 26898994
[TBL] [Abstract][Full Text] [Related]
39. Mapping the antigenicity of the parasites in Leishmania donovani infection by proteome serology.
Forgber M; Basu R; Roychoudhury K; Theinert S; Roy S; Sundar S; Walden P
PLoS One; 2006 Dec; 1(1):e40. PubMed ID: 17183669
[TBL] [Abstract][Full Text] [Related]
40. Leishmania: amastigotes synthesize conserved secretory acid phosphatases during human infection.
Ellis SL; Shakarian AM; Dwyer DM
Exp Parasitol; 1998 Jun; 89(2):161-8. PubMed ID: 9635439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
